Evidence map›Paper›PMID 35834311›Full record

ReviewAngewandte Chemie (International ed. in English)2022

Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging?

Arno Christiaan Gouws, Hendrik Gerhardus Kruger, Olivier Gheysens, Jan Rijn Zeevaart, Thavendran Govender, Tricia Naicker, Thomas Ebenhan

Open access · hybridAbstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Novel Diagnostic Methods for Infective Endocarditis.International journal of molecular sciences · 2024
    Review
  8. First-in-human infection imaging withFrontiers in nuclear medicine · 2024
    Article
  9. The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Arno Christiaan GouwsCatalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, 4000, South Africa.ORCID 0000-0002-9848-719X
Hendrik Gerhardus KrugerCatalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, 4000, South Africa.ORCID 0000-0003-0606-2053
Olivier GheysensDepartment of Nuclear Medicine, Cliniques Universitaires Saint-Luc, and Institute of Clinical and Experimental Research, Université Catholique de Louvain, Brussels, Belgium.ORCID 0000-0001-8478-9675
Jan Rijn ZeevaartNuclear Medicine Research Infrastructure NPC, Pretoria, 0001, South Africa.ORCID 0000-0003-0794-3012
Thavendran GovenderDepartment of Chemistry, University of Zululand, KwaDlangezwa, 3886, South Africa.ORCID 0000-0003-2511-2503
Tricia NaickerCatalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, 4000, South Africa.ORCID 0000-0002-7134-6258
Thomas EbenhanNuclear Medicine Research Infrastructure NPC, Pretoria, 0001, South Africa.ORCID 0000-0002-2038-7324
University of KwaZulu-Natal · ZACliniques Universitaires Saint-Luc · BENorth-West University · ZASouth African Nuclear Energy Corporation (South Africa) · ZAUniversity of Zululand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The excellent features of non-invasive molecular imaging, its progressive technology (real-time, whole-body imaging and quantification), and global impact by a growing infrastructure for positron emission tomography (PET) scanners are encouraging prospects to investigate new concepts, which could transform clinical care of complex infectious diseases. Researchers are aiming towards the extension beyond the routinely available radiopharmaceuticals and are looking for more effective tools that interact directly with causative pathogens. We reviewed and critically evaluated (challenges or pitfalls) antibiotic-derived PET radiopharmaceutical development efforts aimed at infection imaging. We considered both radiotracer development for infection imaging and radio-antibiotic PET imaging supplementing other tools for pharmacologic drug characterization; overall, a total of 20 original PET radiotracers derived from eleven approved antibiotics.

Indexed as

Anti-Bacterial AgentsPositron-Emission TomographyRadiopharmaceuticalsAnti-Bacterial AgentsRadiopharmaceuticalsantibiotic-derived PETimaging of infectionpositron emission tomographyradiolabelingradiotracers

Identifiers

PMID35834311
PMCPMC9826354
OpenAlexW4285386236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.